is developing an mRNA shot that is injected directly into the hearts of heart attack and heart failure patients.The 'vaccine' uses the same technology as the company's and is designed for people weeks or months after a heart attack to help them recover. It works by instructing human heart cells to generate a hormone that is known to improve blood flow, helping restore damaged heart muscles.
Load More
Load More